NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
2003; Springer Science+Business Media; Volume: 169; Issue: 3-4 Linguagem: Inglês
10.1007/s00213-003-1582-z
ISSN1432-2072
AutoresJohn H. Krystal, Deepak Cyril D’Souza, Daniel H. Mathalon, Edward Perry, Ayşenil Belger, Ralph E. Hoffman,
Tópico(s)Treatment of Major Depression
Referência(s)